MolNFT v1 · #61670 · protein
A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than snap-25 substrate
3DSE · Botulinum neurotoxin type a: “A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than…”. X-ray diffraction, 2 ligands (ZN, NI), 4 pockets (best druggability 0.66). MolNFT v1 #61670…
- PDB
- 3DSE
- Type
- protein
- Length
- 394 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Botulinum neurotoxin type a
- EC
- 3.4.24.69
- UniProt
- A5HZZ9
- Ligands
- ZN, NI
- Pockets
- 4 · best druggability 0.66
Structure
x-ray diffraction · 1 distinct chain · 32% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Botulinum neurotoxin type a (EC 3.4.24.69) | protein | 394 | 32% helix, 19% strand | A5HZZ9 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 439 | 0.66 | 0.79 | 49 | empty |
| 2 | 117 | 0.38 | 0.74 | 22 | empty |
| 3 | 67 | 0.38 | 0.79 | 18 | empty |
| 4 | 50 | 0.33 | 0.78 | 12 | empty |
Compared structures
- 3DSE · A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A5HZZ9
- Elsewhere: RCSB PDB 3DSE · PDBe 3DSE · UniProt A5HZZ9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.